If an extra isotretinoin dose has been taken, obtain prompt advice from a poison-information service or an appropriate clinician. Give the exact product, strength, number of capsules and times. Do not wait for visible symptoms to decide whether assessment is needed.

In the United States, the cited label identifies Poison Help at 1-800-222-1222 as a contact for overdose advice. Elsewhere, use the relevant local poison or urgent medical service. Severe symptoms or immediate danger requires emergency care.

Establish the actual exposure

DetailWhy it matters
Capsule strength and numberThe same capsule count can represent different amounts
FormulationProduct differences may matter to interpreting exposure
Times takenSeparates one error from repeated additional doses
Person exposedA child or another adult needs their own assessment
Other medicines or supplementsIdentifies additional relevant exposures
Pregnancy possibilityRequires explicit reproductive-risk consideration

If the amount is uncertain, state the uncertainty. Do not choose a reassuring estimate or use a body-weight calculator to decide a private harmless-excess threshold.

Do not correct the mistake at home

Do not induce vomiting or take vitamins, food or another medicine to neutralize the dose. An improvised intervention can create additional harm without reliably changing the exposure.

Do not take further capsules while seeking instructions about the event and the next dose. If essential unrelated medicines are involved, obtain advice rather than independently stopping the entire regimen.

Keep packaging available when practical, but do not delay urgent help to find it. An unverified or combined product should be described as such so the treating team can address uncertain ingredients.

Symptoms still need their own assessment

The label describes overdose-associated symptoms including vomiting, abdominal discomfort, headache, dizziness and impaired coordination. Their absence does not establish that another capsule is appropriate.

Altered consciousness, a seizure, serious injury or another severe presentation requires emergency assessment. Do not drive yourself while impaired.

The advice service can determine whether observation or further assessment is necessary for the actual exposure. A general article cannot provide a universal number of capsules below which every patient is safe.

Pregnancy potential must be disclosed immediately

Isotretinoin is highly harmful to a developing pregnancy. Tell the treating team if the exposed person is pregnant, might be pregnant or could become pregnant. A single dosing error does not remove the need for that assessment.

The label calls for pregnancy evaluation in patients who can become pregnant presenting with overdose. Testing and counseling need to account for timing; a negative result immediately after a recent possible conception does not answer every question.

Do not continue the course while seeking informal reassurance that the excess was too small to matter. Obtain the appropriate medical instructions for the exposure and ongoing treatment.

Overdose has additional labeled precautions

The cited US label advises male patients to use a condom or avoid reproductive sexual activity with a partner who is or may be pregnant for one month after overdose. It also advises all patients not to donate blood for at least one month after overdose.

These instructions concern overdose and should not be confused with conclusions about paternal exposure during an ordinary prescribed course. Tell the clinician about reproductive circumstances so the relevant advice is applied correctly.

Follow the treating team's guidance about ongoing pregnancy-prevention and testing requirements. An interrupted supply does not automatically end the safety period associated with prior exposure.

Prevent recurrence once the event is assessed

  • Confirm the current strength, product and capsule count in writing.
  • Separate obsolete and current directions after a dose change.
  • Identify a practical way to record whether the scheduled dose was taken.
  • Keep the medicine secure from unintended users.
  • Resolve formulation or pharmacy-supply discrepancies before use.

Do not take extra capsules later to compensate for a pause advised after the event. The next regimen should be clarified by the responsible team.

The first priority is accurate assessment, followed by clear prevention of the same error. A previous anecdote, normal appearance or lack of immediate symptoms cannot replace exposure-specific advice.